Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
… is a particularly problematic molecule due to risks of hypoglycemia due high inter- and intra-… therapy to control glucose levels in rats with type 2 diabetes. When orally administered, the …..... Read More